Table 2.
Histopathology of the 131 breast masses
| Histopathology | Samples | Percent (%) |
|---|---|---|
| Malignant (N = 16) | ||
| Invasive ductal carcinoma (with and without associated ductal carcinoma in situ) | 14 | 87.50 |
| Mixed pleomorphic invasive lobular and ductal carcinoma | 1 | 6.25 |
| Intraductal papillary carcinoma | 1 | 6.25 |
| Benign (N = 115) | ||
| Fibroadenomaa | 51 | 44.35 |
| Fibrocystic changes | 21 | 18.26 |
| Inflammatory process (including chronic inflammation, abscess and idiopathic granulomatous mastitis) | 11 | 9.57 |
| Other benign | 9 | 7.83 |
| Papillary lesions (including benign intraductal papillomas and one papillary lesion with atypia that was not upgraded to malignancy with surgical excisiona) | 8 | 6.96 |
| Stromal fibrosis | 7 | 6.09 |
| Fat necrosis | 2 | 1.74 |
| Lymph node/lymphoid tissuea | 2 | 1.74 |
| Pseudoangiomatous stromal hyperplasia (PASH) | 2 | 1.74 |
| Nipple adenoma | 1 | 0.87 |
| Atypical ductal hyperplasia (ADH) with associated atypical papillary lesion (not upgraded to malignancy with surgical excision)a | 1 | 0.87 |
aSix of the 131 lesions were recommended for surgical excisional biopsy. 4 of the 6 patients obtained surgical excisional biopsy and none were upgraded to malignancy